Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial
ChAdOx1 nCoV-19 疫苗在年轻和老年人中以初免-加强方案接种的安全性和免疫原性（COV002）：一项单盲、随机、对照、 2/3 期试验
期刊:Lancet
影响因子:98.4
doi:10.1016/S0140-6736(20)32466-1
Maheshi N Ramasamy, Angela M Minassian, Katie J Ewer, Amy L Flaxman, Pedro M Folegatti, Daniel R Owens, Merryn Voysey, Parvinder K Aley, Brian Angus, Gavin Babbage, Sandra Belij-Rammerstorfer, Lisa Berry, Sagida Bibi, Mustapha Bittaye, Katrina Cathie, Harry Chappell, Sue Charlton, Paola Cicconi, Eli
